GovChime
Notice ID: 403af7f4043348c3bb4c645238dfc252Sources SoughtArchived

6515--NX EQ Electrosurgical Units, Argon-Enhanced Coagulation (VA-26-00034663) (VA-26-00034663)

Archived on March 27, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
11:59 PM EST
Posted
January 12, 2026
Notice type
Sources Sought
NAICS
339112: Surgical and Medical Instrument Manufacturing
Agency
Department of Veterans Affairs

Notice details

Office
STRATEGIC ACQUISITION CENTER FREDERICKSBURG (36C10G)
Place of performance
Enterprise-wide
Last updated
Nov 4, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
36C10G26Q0035
Notice ID
403af7f4043348c3bb4c645238dfc252

Description

DESCRIPTION The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified Electrosurgical Units (ESUs); Argon-Enhanced Coagulation product line as a candidate for a VA-wide (otherwise referred to as national ) single Requirements contract award. The Department of Veterans Affairs (DVA) Office of Procurement, Acquisition and Logistics (OPAL) Strategic Acquisition Center (SAC) on behalf of VHA is issuing this Request for Information (RFI) in accordance with the FAR 10.002(b)(2) to determine the availability and technical capabilities of qualified sources. The period of performance will consist of a base of 12-months with four 12-month option periods from the date of award. The SAC in conjunction with VHA is seeking a qualified source to manufacture Electrosurgical Units (ESUs); Argon-Enhanced Coagulation on an agency wide basis. VA intends to award a Brand Name or Equal (BNOE) single award Requirements contract for this requirement IAW with FAR 16.503. Vendors will be required to deliver Electrosurgical Units (ESUs); Argon-Enhanced Coagulation to VA medical centers and facilities throughout the United States. The anticipated period of performance is for one (1) 12-month base period with four (4) 12-month option periods from the date of award. However, the Government's decision as to whether or not to continue with the contract, upon annual review, will be based upon successful performance during each previous year and continued need. The Contractor must demonstrate the ability to meet all requirements for the solicitation. The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 Surgical and Medical Instrument Manufacturing and the associated size standard is 1,000 employees. The FAR Provision found at 52.204-7 requires that All interested Offerors must be registered in SAM prior to submitting an offer or proposal. You may access the SAM website at Home | SAM.gov. All offerors must be certified with the appropriate NAICS code on the SAM website. All SDVOSB/VOSB offerors must be verified in the Small Business Administration (SBA) database at Veteran Small Business Certification (VetCert) database at: Veteran Small Business Certification (sba.gov) at the time of proposal submission. This notice is for planning purposes only and does not constitute a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice. This Sources Sought Notice is part of a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for, or award, a competitive contract. It is emphasized that this is a notice solely for planning and informational purposes. 2.0 SCOPE Electrosurgical Units (ESUs); Argon-Enhanced Coagulation (AEC) are advanced, energy based surgical systems used to perform precise tissue coagulation and devitalization across Veterans Affairs Medical Centers (VAMCs), particularly in operating rooms (OR), procedural suites, and endoscopy units. They deliver radiofrequency (RF) energy through specialized electrodes while directing a controlled flow of inert argon gas to create a conductive plasma at the tissue surface. This results in uniform, noncontact coagulation with minimal tissue penetration, improved visualization, and reduced bleeding. ESUs with AEC are designed to enhance surgical efficiency, improve hemostasis, and support consistent, replicable outcomes across a range of open, laparoscopic, and endoscopic procedures. These systems provide real-time, automated control of power delivery, argon flow, and activation mode, with integrated safety monitoring and configurable presets for procedure-specific use. They are optimized to increase clinical efficiency and reduce complications through precision energy delivery, reliable tissue effect profiles, and comprehensive safety interlocks. The following Contract Line Items are being considered: Contract Line Item# Brand Part Number Description 0001 ERBE USA INC. VIO® 3 0001A ERBE USA INC. 10160-000 VIO® Electrosurgical unit 0001B ERBE USA INC. 20189-353 Two-pedal foot switch, VIO® 3 ReMode®, bracket, middle piece 0001C ERBE USA INC. 20188-350 One-pedal foot switch, VIO® 3 ReMode® 0001D ERBE USA INC. 20180-000 VIO® CART System carrier for VIO® 0001E ERBE USA INC. 20180-010 Wire basket, 339 x 205 x 155 / 100 mm 0002 ERBE USA INC. Attachment Sets 0002A ERBE USA INC. 20180-140 Fastening set for VIO® 3 on VIO® Cart 0002B ERBE USA INC. 20180-143 Fastening set VIO® 3 for APC® 3 on boom mount 0002C ERBE USA INC. 20180-144 Fastening set VIO® 3 for APC® 3 on ERBEJET® 2 0003 ERBE USA INC. Instrument cables from Erbe 0003A ERBE USA INC. 20192-133 Monopolar cable MO 3Pin; MIS OD 4mm; L 4.5m 0003B ERBE USA INC. 20192-134 Monopolar cable MO 3Pin; OD 4.5mm pin; L 4.5m 0003C ERBE USA INC. 20192-135 Monopolar cable MO 3Pin; OD 3mm socket; L 4.5m 0003D ERBE USA INC. 20196-064 Bipolar cable BI 2Pin28; ang.; forceps; L 4.5m 0003E ERBE USA INC. 20196-067 Bipolar cable BI 2Pin28; grasp. forceps; L 4.5m 0003F ERBE USA INC. 20196-127 Bipolar cable BI 2Pin28; forceps 2Pin; L 4m 0003G ERBE USA INC. 21196-115 Bipolar Conecting Cable; MF-U Olympus Resectoscope; L 4.5m 0003H ERBE USA INC. 21196-118 Bipolar Connecting Cable; MF-U Storz Resectoscope; L 4.5m 0003I ERBE USA INC. 21196-119 Bipolar Connecting Cable; MF-U Wolf Resectoscope; L 4.5m 0004 ERBE USA INC. VIO® 300 D 0004A ERBE USA INC. 10140-100 VIO® 300 D Electrosurgical Unit 120V/60HZ UL , Software Version 2.X Constant Voltage 0004B ERBE USA INC. 20189-305 VIO® two pedal footswitch w/ReMode® w/Bracket (Remode Feature Allows Changing between Preset Programs) 0004C ERBE USA INC. 20180 131 Connection Adapter, Cryo Probe to Erbokryo CA 0004D ERBE USA INC. 20183-053 Adapter for BICAP or Gold Probe 0004E ERBE USA INC. 20193-084 NESSY® Omega monitoring pad with cable (50 per case) 0004F ERBE USA INC. 20180-000 VIO® Cart with footswitch holder, cable wrap and 1 tank fixation kit 0004G ERBE USA INC. 20180-010 VIO® Cart wire basket 0004H ERBE USA INC. 20180-131 VIO®/APC® 2 to VIO® Cart fastening set (with grounding cable) The Department of Veterans Affairs (VA) is seeking vendors who can provide Erbe® VIO 3 Electrosurgical Units (ESUs); Argon-Enhanced Coagulation system or equal as listed above which meet all the following salient characteristics: Vendors may quote any product solution or configuration so long as they meet the salient characteristics. Products quoted in the technical volume must be captured on the Vendor s pricing volume (Attachment A, Price Cost Schedule) of the solicitation. Vendors may quote any additional ancillary products which they deem to be essential to the functionality of the proposed solution; these items must be captured in the Vendor s pricing volume with a quantity of zero. Apply the following SCs to CLIN s 0001-0004 SC # SALIENT CHARACTERISTICS METHOD OF EVALUATION SC1 Must be cleared by the U.S. Food and Drug Administration (FDA) as an electrosurgical generator with compatible argon-enhanced coagulation capability for cutting and coagulation of tissue in general, laparoscopic, and endoscopic surgery, including hemostasis and devitalization of soft tissues. Literature Review SC2 Must provide a centralized color touchscreen user interface that allows the operator to select, monitor, and adjust at minimum: Electrosurgical mode (e.g., monopolar cut, monopolar coag, bipolar, argon coagulation); Output power settings (watts); Application-relevant parameters (e.g., argon gas flow and effect settings for argon-enhanced coagulation); and Treatment or activation time (timer or activation counters). Literature Review SC3 Must be compatible with a range of monopolar and bipolar instruments, as well as compatible argon probes/catheters and applicators, in various working lengths suitable for open and endoscopic procedures. Literature Review SC4 Must consist of modular argon plasma capability with adjustable gas flow rates (0.1 to 6 L/min) and multiple APC waveforms (precise, pulsed, forced) for non-contact surface coagulation, enabling effective hemostasis and tissue ablation in gastrointestinal, respiratory, and other anatomical applications. Literature Review SC5 Must have advanced neutral electrode monitoring (such as NESSY technology) that dynamically tracks patient impedance levels and return electrode contact/orientation, along with proprietary spark recognition and control algorithms to minimize carbonization, tissue adhesion, and unintended thermal injury. Literature Review SC6 Must consist of compact design with multiple socket configurations (monopolar, bipolar, universal connections) accommodating international and manufacturer-specific instrument standards, wireless and wired footswitch options, and compatibility with smoke evacuation and insufflation systems for streamlined OR workflow. Literature Review SC7 Must include a minimum one year manufacturer warranty covering parts and labor, with availability of installation, user training, and ongoing service support programs. Literature Review Evaluation Sub-factors 1. Design: Design features and function will be evaluated based on, but not limited to, the following: Centralized touchscreen user interface: Large, color touchscreen with logical application-oriented men for quick selection and confirmation of modes to include APC settings. Multi-instrument connectivity and APC integration to include argon probes and APC hand pieces. Procedure and instrument-based presents: Recognizes instrument and procedure-specific programs that automatically load parameters and standardizes set-up. 2. Performance: Performance capabilities, features and functions of the device offered will be evaluated for technical performance, reliability, and clinical effectiveness. These elements include, but are not limited to: High dynamic power delivery: Power supply is able to maintain stable output under variable loads and APC modes. Rapid response measurement rate: High measurement of frequency of target tissue effects across different tissue types and cutting speeds supporting argon-assisted coagulation lines. Multi-modality support: Concurrent support for monopolar, bipolar, and hybrid/argon-assisted applications across platforms without swapping generators during an on-going procedure. 3. Safety: All features and functions of the equipment shall be evaluated for the ability to be safely installed, secured, and protected against harm; physical or any form. These elements include, but are not limited to: Regulatory compliance and clearances: FDA 510(K) clearance status. Systems and operational features safety related to electrical and argon-gas. Warning and alarms capability 4. Quality/Construction/Training: Elements will include, but are not limited to: Robust construction and medical-grade standards. Power consumption, backup power, and energy efficiency. Terms and conditions of installation, training, and service agreement programs. Expected life cycle to include sanitation, infection control, and maintenance. For each product (brand name and part number), the response must include descriptive literature demonstrating the product meets or exceeds the SCs specified above. The Government's intent is to include all ancillary items to ensure the equipment can function as designed by the Original Equipment Manufacturer (OEM) and as clinically required. Vendors are encouraged to provide any product solution or configuration so long as they meet the SCs. Additionally, responses can include any additional product that may be beneficial. These items must be clearly identified by brand name and part number. Responses to this Sources Sought Notice shall include the following: Does vendor offer an annual service plan, Yes or No? If Yes: What does the plan cover? Does plan cover software updates only? Does the plan cover parts repair or replacement only? Does the plan cover both software and parts? If applicable, vendors are requested to provide documentation that shows information on their service plan. Is the service provided by the OEM or a subcontractor? Full name and address of company SAM Unique Entity Identifier (UEI) / CAGE Code Business Size Manufacturer or Distributor If the distributor, provide manufacturer s full name, business size and address. Country of Origin designation for all products. Ability to provide uninterrupted supply of products on a national scale. Technical Literature that clearly shows product(s) meet the identified salient characteristics and page numbers where each salient characteristic is met. Any additional product solution or configuration that would be beneficial to the clinical functionality of the product line identified. Authorized Distributor Letter Certified by OEM with a current date. Although not required, vendors responding to this Sources Sought may also submit a Capabilities Statement. Contractors submitting capability statements in response to this RFI must specifically address the questions outlined above. Generic capability statements that do not directly pertain to this RFI will not be considered. Additionally, links requesting capability statements or further information will not be accessed. All responses must be submitted as an actual file attachment.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Daleta Coles
Contract Specialist
Fax: Hosea Berkley

Documents

Files (1)

  • 36C10G26Q0035.docx

    42 KBAdded in Sources Sought version 3Posted
    Download

Lifecycle

  1. 3
    Version 3Sources SoughtArchivedCurrent

    6515--NX EQ Electrosurgical Units, Argon-Enhanced Coagulation (VA-26-00034663) (VA-26-00034663)

    Notice 403af7f4043348c3bb4c645238dfc252 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Solicitation Number:  36C10X27Q0014  Notice Type:  Combined Synopsis/Solicitation  This is a combined synopsis/solicitation for brand name, or equal commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation will not be issued. Solicitation number 36C10X27Q0014 is issued for this combined synopsis/solicitation; this solicitation is being issued as a Request for Quote (RFQ). This combined synopsis/solicitation incorporates provisions and clauses in effect through Federal Acquisition Circular (FAC) 2026-01, dated 13 March 2026. Requirement Description: VA has a requirement to purchase Autotransfusion Units to deliver patient care to its VA Medical Centers around the country. An Autotransfusion Units also known as an autologous blood recovery system, is a system that provides hospitals with an easy-to-use, reliable way to recover a patient s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular and OBGYN surgeries. Once recovered, the blood is washed and delivered to a product bag. The complete system is designed to be intuitive and flexible for optimal performance, supporting exceptional patient care. A single award Requirements contract will be awarded as a Brand Name or Equal in accordance with all terms, conditions, provisions, specifications, and schedule of this solicitation herein. Quotes shall contain the terms for cost/price and technical capabilities of the brand name or equal equipment. The Government reserves the right to award without discussions.  The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 Surgical and Medical Instrument Manufacturing, Product Service Code: 6515 Medical and Surgical Instruments, Equipment, and Supplies. The associated size standard is 800 employees. This procurement action is Unrestricted Full and Open. This acquisition is for a single award Requirements contract in accordance with FAR Part 16.5 for Haemonetics Call Saver® Elite® + brand name or equal to Autotransfusion Units as identified in ATTACHMENT A PRICE COST SCHEDULE - NX EQ AUTOTRANSFUSION UNITS. All interested companies shall provide a QUOTE for all Contract Line-Item Numbers (CLINs) listed in ATTACHMENT A PRICE COST SCHEDULE - NX EQ AUTOTRANSFUSION UNITS. The ordering period is for one 12-month base year with four 12-month option years. Delivery is a FOB destination. Firm-Fixed Price Orders will be placed against this contract in writing and will provide the delivery locations, delivery dates and exact quantities.  The FAR provision at 52.212-1, Instructions to Offerors Commercial Products and Commercial Services, applies to this acquisition including attached addenda to the provision. The FAR provision at 52.212-2, Evaluation -- Commercial Products and Commercial Services Items, and the specific evaluation criteria as attached addenda also applies to this acquisition. Clause 52.212-4, Terms and Conditions -- Commercial Products and Commercial Services, applies to this acquisition and a statement regarding any addenda to the clause. Addendum is attached. All interested quoters must be registered in the System for Award Management (SAM) prior to submitting a quote. You may access SAM at https://sam.gov/SAM/. Questions regarding this combined synopsis/solicitation are due via email by 10:00 AM Eastern Standard Time (EST) on November 16, 2026, to Contract Specialist, Jalima Jones at Jalima.Jones@va.gov and Contracting Officer, Sara Vickroy at Sara.Vickroy@va.gov No calls will be accepted. Quotes are due via email by 10:00 AM EST on November 23, 2026, to Contract Specialist, Jalima Jones at Jalima.Jones@va.gov and Contracting Officer, Sara Vickroy at Sara.Vickroy@va.gov SCOPE OF WORK   The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified Autotransfusion Units product line as a candidate for a VA-wide (otherwise referred to as national ) single Requirements contract award.  Autotransfusion Units, also known as an autologous blood recovery system, is a system that provides hospitals with an easy-to-use, reliable way to recover a patient s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular and OBGYN surgeries. Once recovered, the blood is washed and delivered to a product bag. The complete system is designed to be intuitive and flexible for optimal performance, supporting exceptional patient care. The Contractor must demonstrate the ability to meet all requirements for the solicitation. The objective is to provide Autotransfusion Units to be used by VHA clinicians throughout the United States and its territories. The period of performance is for one 12-month base period with four 12-month option periods. 2. REQUIREMENT This requirement will be, Brand Name or Equal which requires the quoter indicate that each product being offered as an equal product to Haemonetics Call Saver® Elite® + or equal Autotransfusion Units. For each equal product, the quoter must include a description reflecting the salient characteristics (SCs) and level of quality that will satisfy the salient physical, functional, or performance characteristics of the equal product(s) specified in the solicitation. The quoter must also clearly identify the item by brand name (if any) and make/model number. Finally, the offeror must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer (CO) and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements. The following line-items comprise the Autotransfusion Units product line: Contract Line-Item Number Brand Part Number Description 0001 Haemonetics 00205-00 RESERVOIR, HARD-SHELL, 150u 0002 Haemonetics 00208-00 BASIC A & A ASSEMBLY, LN 208 0003 Haemonetics 00220-00 RESERVOIR, HARD-SHELL, 20U 0004 Haemonetics 00245-00 RBC BAG W/TWIST-LOCK CONNECTOR 0005 Haemonetics CSE-B-1000 BAG ASSY, WASTE, 10L 0006 Haemonetics CSE-FP-125V CE ELITE FASTPACK,125mL,150u 0007 Haemonetics CSE-FP-225V CS ELITE FASTPACK,225ML,150U 0008 Haemonetics CSE-P-125 CS ELITE PROCESSING KIT, 125ML 0009 Haemonetics CSE-P-225 CS ELITE PROCESSING KIT, 225ML 0010 Haemonetics CSE-P-70 CS ELITE PROCESSING KIT, 70ML 0011 Haemonetics CSE-SQ-1000 SEQUESTRATION KIT, CSE-SQ-1000 0012 Haemonetics HAR-A-1000 VACUUM LINE, FILTERED 0013 Haemonetics HAR-A-0013 ASPIRATION & ANTICOAG LINE 0014 Haemonetics CSE-EX-US CELL SAVER ELITE PLUS, US 0015 Haemonetics RECERTIFICATION ANNUAL ONLINE RECERTIFICATION 0016 Haemonetics Cell saver Service 1 Year Platinum Service Agreement 0017 Haemonetics Training Tuition Training The Department of Veterans Affairs (VA) is seeking vendors who can provide Haemonetics Call Saver® Elite® + brand name or equal to Autotransfusion Units as listed above which meet all the following salient characteristics. Vendors may quote any product solution or configuration so long as they meet the salient characteristics. Products quoted in the technical volume must be captured on the Vendor s pricing volume (Attachment A, Price Cost Schedule) of the solicitation. Vendors may quote any additional ancillary products which they deem to be essential to the functionality of the proposed solution; these items must be captured in the Vendor s pricing volume with a quantity of zero. SC # Salient Characteristics Method of Evaluation Applicable CLINs Page # Where SC is Found in Technical Literature SC1 Collects, separates, washes, and concentrates red blood cells to produce packed RBCs for reinfusion. Literature Review 0014 SC2 Provides multiple automated processing modes (standard, low volume/pediatric, rapid/emergency) with defined throughput/output rates that support continuous or rapid access to washed RBCs during surgery. Literature Review 0014 SC3 Produces high hematocrit washed RBCs with high RBC recovery achieving a strong removal of non RBC components (plasma proteins, free hemoglobin, anticoagulant, potassium, fat). Literature Review 0014 SC4 Provides an intuitive touchscreen user interface with guided workflows and clear process / status indicators Literature Review 0014 SC5 Compact, mobile system suitable for OR environments, with ergonomic features that support perfusionist / auto-transfusionist workflow. Literature Review 0014 SC6 Includes alarms and safety interlocks for process parameters, vacuum, fluid levels, and product quality, with reliability appropriate for high use OR settings. Literature Review 0014 SC7 Cleared/approved as an autotransfusion device under applicable regulations and standards Literature Review 0014 SC # Salient Characteristics Method of Evaluation Applicable CLINs Page # Where SC is Found in Technical Literature SC8 Uses single use disposable sets that are quick to install and prime, minimizing setup time and steps. Literature Review 0001 - 0013 SC # Salient Characteristics Method of Evaluation Applicable CLINs Page # Where SC is Found in Technical Literature SC9 Supports intraoperative and postoperative autologous blood collection, processing, and reinfusion for medium to high blood loss procedures (cardiac, orthopedic, trauma, vascular, transplant, OBGYN).. Literature Review 0001 - 0014 The following attachments are incorporated by reference. All criteria outlined in the attachments are applicable to this combined synopsis/solicitation.
81%
Combined Synopsis11/23/2026
36C24125R0116 Anesthesia procurement
81%
Pre-Solicitation11/02/2026
DESCRIPTION The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified the Autotransfusion Units product line as a candidate for a VA-wide (otherwise referred to as national ) single Requirements contract award. The Department of Veterans Affairs (DVA) Office of Procurement, Acquisition and Logistics (OPAL) Enterprise Procurement Office (EPO) on behalf of VHA is issuing this Sources Sought Notice in accordance with the FAR 10.002(b)(2) to determine the availability and technical capabilities of qualified sources. The EPO in conjunction with VHA is seeking a qualified source to provide Haemonetics Call Saver® Elite® + brand name or equal to Autotransfusion Units on an agency wide basis. VA intends to award a Requirements Contract with Firm-Fixed Price (FFP) orders IAW FAR 16.503, Requirements Contract to a supplier of this equipment. Vendors will be required to deliver the Autotransfusion Units to VA medical centers and facilities throughout the United States and its territories. The anticipated period of performance is for one 12-month base period with four 12-month option periods from the date of award. However, the Government's decision as to whether to continue with the contract, upon annual review, will be based upon successful performance during each previous year and continued need. The Contractor must demonstrate the ability to meet all requirements for the solicitation. The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 Surgical and Medical Instrument Manufacturing, Product Service Code: 6515 Medical and Surgical Instruments, Equipment, and Supplies. The FAR Provision found at 52.204-7(b)(1) requires that All interested Offerors must be registered in SAM.gov prior to submitting an offer or quotation. You may access the website at SAM.gov | Home. All offerors must be certified with the appropriate NAICS code on the SAM website. All SDVOSB/VOSB offerors must be verified in the SBA database at: https://veterans.certify.sba.gov/#search at the time of quote submission. Submissions for this source sought shall be submitted by email no later than September 25, 2026, at 10:00 am EST to all the following: Sara.Vickroy@va.gov Jalima.Jones@va.gov This notice is for planning purposes only and does not constitute a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice. This Sources Sought Notice is part of a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for, or award, a competitive contract. It is emphasized that this is a notice solely for planning and informational purposes. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. The Government may or may not issue a solicitation as a result of this notice. There is no solicitation available at this time. 2.0 SCOPE Autotransfusion Unit, also known as an autologous blood recovery system, is a system that provides hospitals with an easy-to-use, reliable way to recover a patient s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular and OBGYN surgeries. Once recovered, the blood is washed and delivered to a product bag. The complete system is designed to be intuitive and flexible for optimal performance, supporting exceptional patient care. The following Contract Line-Items Number (CLIN) are being considered: CLIN Manufacturer Part Number Description 0001 Haemonetics 00205-00 RESERVOIR, HARD-SHELL, 150u 0002 Haemonetics 00208-00 BASIC A & A ASSEMBLY, LN 208 0003 Haemonetics 00220-00 RESERVOIR, HARD-SHELL, 20U 0004 Haemonetics 00245-00 RBC BAG W/TWIST-LOCK CONNECTOR 0005 Haemonetics CSE-B-1000 BAG ASSY, WASTE, 10L 0006 Haemonetics CSE-FP-125V CE ELITE FASTPACK,125mL,150u 0007 Haemonetics CSE-FP-225V CS ELITE FASTPACK,225ML,150U 0008 Haemonetics CSE-P-125 CS ELITE PROCESSING KIT, 125ML 0009 Haemonetics CSE-P-225 CS ELITE PROCESSING KIT, 225ML 0010 Haemonetics CSE-P-70 CS ELITE PROCESSING KIT, 70ML 0011 Haemonetics CSE-SQ-1000 SEQUESTRATION KIT, CSE-SQ-1000 0012 Haemonetics HAR-A-1000 VACUUM LINE, FILTERED 0013 Haemonetics HAR-A-0013 ASPIRATION & ANTICOAG LINE 0014 Haemonetics CSE-EX-US CELL SAVER ELITE PLUS, US 0015 Haemonetics RECERTIFICATION ANNUAL ONLINE RECERTIFICATION 0016 Haemonetics Cellsaver Service 1 Year Platinum Service Agreement 0017 Haemonetics TRAINING TUITION Training (Operation of the System) The Department of Veterans Affairs (VA) is seeking vendors who can provide Haemonetics Call Saver® Elite® + brand name, or equal to Autotransfusion Units as listed above or equal commodities which meet all the following salient characteristics (SCs): CLIN 0014 applies to the following SCs SC # SALIENT CHARACTERISTICS Applicable CLIN METHOD OF EVALUATION SC 1 Collects, separates, washes, and concentrates red blood cells to produce packed RBCs for reinfusion 0014 Literature Review SC 2 Provides multiple automated processing modes (standard, low volume/pediatric, rapid/emergency) with defined throughput/output rates that support continuous or rapid access to washed RBCs during surgery. 0014 Literature Review SC 3 Produces high hematocrit washed RBCs with high RBC recovery achieving a strong removal of non RBC components (plasma proteins, free hemoglobin, anticoagulant, potassium, fat). 0014 Literature Review SC 4 Provides an intuitive touchscreen user interface with guided workflows and clear process / status indicators 0014 Literature Review SC 5 Compact, mobile system suitable for OR environments, with ergonomic features that support perfusionist / auto transfusionist workflow. 0014 Literature Review SC 6 Includes alarms and safety interlocks for process parameters, vacuum, fluid levels, and product quality, with reliability appropriate for high use OR settings. 0014 Literature Review SC 7 Cleared/approved as an autotransfusion device under applicable regulations and standards 0014 Literature Review CLINs 0001-0013 applies to the following SC SC # SALIENT CHARACTERISTICS Applicable CLIN METHOD OF EVALUATION SC 8 Uses single use disposable sets that are quick to install and prime, minimizing setup time and steps. 0001-0013 Literature Review CLINs 0001-0014 applies to the following SC SC # SALIENT CHARACTERISTICS Applicable CLIN METHOD OF EVALUATION SC 9 Supports intraoperative and postoperative autologous blood collection, processing, and reinfusion for medium to high blood loss procedures (cardiac, orthopedic, trauma, vascular, transplant, OBGYN). 0001-0014 Literature Review For each product (brand name and part number), the response must include descriptive literature demonstrating the product meets or exceeds the salient characteristics specified above. The Government's intent is to include all ancillary items to ensure the equipment can function as designed by the Original Equipment Manufacturer (OEM) and as clinically required. Vendors are encouraged to provide any product solution or configuration so long as they meet the salient characteristics. Additionally, responses can include any additional product that may be beneficial. These items must be clearly identified by brand name and part number. Responses to this Sources Sought Notice shall include the following: Does vendor offer an annual service plan, Yes or No? If Yes: What does the plan cover? Does plan cover software updates only? Does the plan cover parts repair or replacement only? Does the plan cover both software and parts? Vendors are requested to provide documentation that shows information on their service plan. Is the service provided by the OEM or a subcontractor? Full name and address of company CAGE Code/ SAM UIE Business Size Manufacturer or Distributor If the distributor provides full name, business size and address of manufacturer. Country of Origin designation for all products Ability to provide uninterrupted supply of products on a national scale. Technical Literature that clearly shows product(s) meets the identified salient characteristics and page numbers where each salient characteristic is met. Any additional product solution or configuration that would be beneficial to the clinical functionality of the product line identified. Authorized Distributor Letter Certified by OEM with a current date. Although not required, vendors responding to this Sources Sought may also submit a Capabilities Statement.
81%
Market Research09/25/2026
The Department of Veterans Affairs (VA) intends to solicit for anesthesia units (to include warranty, maintenance and training) for inclusion into the National Equipment Catalog (NEC). This is a Request for Proposals (RFP) for anesthesia units at the national level. The Department of Veterans Affairs intends to establish Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts. This solicitation will result in multiple awards. The ID/IQs will cover the entire nation. The contract s performance period is for ten years, inclusive of a five-year base period and one, five-year option period. Telephone requests for information or questions will NOT be accepted. PLEASE SUBMIT QUESTIONS REGARDING THIS RFP NO LATER THAN 4PM EST ON FRIDAY, AUGUST 21, 2026. QUESTIONS OR COMMENTS SHOULD BE SUBMITTED TO THE CONTRACT SPECIALIST, MELANIE STOCKMAN AT melanie.stockman@va.gov .
81%
Combined Synopsis10/05/2026
The Department of Veterans Affairs (VA) intends to solicit for anesthesia units (to include warranty, maintenance and training) for inclusion into the National Equipment Catalog (NEC). This is a Request for Proposals (RFP) for anesthesia units at the national level. The Department of Veterans Affairs intends to establish Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts. This solicitation will result in multiple awards. The ID/IQs will cover the entire nation. The contract s performance period is for ten years, inclusive of a five-year base period and one, five-year option period. Telephone requests for information or questions will NOT be accepted. PLEASE SUBMIT QUESTIONS REGARDING THIS RFP NO LATER THAN 4PM EST ON FRIDAY, AUGUST 21, 2026. QUESTIONS OR COMMENTS SHOULD BE SUBMITTED TO THE CONTRACT SPECIALIST, MELANIE STOCKMAN AT melanie.stockman@va.gov .
81%
Combined Synopsis09/11/2026

Additional Details

Solicitation Number

36C10G26Q0035

Archive Date

Mar 27, 2026

Office Address

FREDERICKSBURG, VA, 22408